program nanotme 2021
23-24 September, Enschede The Netherlands
Thursday 23 September 2021 | |||
Dutch time (CEST) | |||
09:00 | Welcome speech | Jai Prakash and Yuval Shaked | |
09:15 | Keynote lecture | Emile Voest | The battle between tumor and immune cells in cancer patients: New insights |
Session 1: Tumor Immune microenvironment - Session chair: Yuval Shaked | |||
09:50 | Karin de Visser | Immune Complexity of Metastatic Breast Cancer: Towards personalized immune intervention strategies | |
10:15 | Xiaoyuan (Shawn) Chen | Modulating Immunosuppressive Tumor Environment with Nanomedicine | |
10:40 | Zvika Granot | Neutrophil-specific targeting as cancer immunotherapy | |
11:05 | Break | ||
Session 2: Nanomedicine and TME - Session chair: Zvika Granot | |||
11:30 | Ronit Satchi-Fainaro | Fighting p-selectin-expressing glioblastoma in 3 dimensions | |
11:55 | Veronique Preat | Nanomedicine to target the microenvironment of colorectal cancer and glioblastoma | |
12:20 | Maria Vicent | Polypeptide-based nanoconjugates as versatile modulators of tumor microenvironment | |
12:45 | Lunch | Breakrooms for discussion and networking | |
Session 3: Short talks - Session chair: Twan Lammers | |||
13:45 | Triantafyllos Stylianopoulos | Tumor microenvironment normalization with nanomedicine and metronomic therapy: implications for immunotherapy | |
13:57 | Nora Dekoning | Nanoparticles as delivery vehicles for gene transport to the tumor microenvironment and endothelial cells | |
14:09 | Marcel Heinrich | Mimicking blood vessel collapse in pancreatic cancer using 3d engineered vascularized tissues | |
14:21 | Dave S.B. Hoon | Spatial analysis of TME microglia in immune checkpoint inhibitor resistant and non-treated melanoma brain metastasis | |
14:33 | Andrea Abaurrea | Stromal oncostatin m axis promotes breast cancer progression | |
14:45 | Ninh (Irene) La-Beck | Targeting tumor immunologic milieu with liposomal amino-bisphosphonates | |
15:00 | Break | ||
15:15 | Publishing in Nature | Anna Dart - Nature publishing | Publishing in the Nature portfolio journals |
Session 4: Nanomedicine and TME - Session chair: Jai Prakash | |||
15:45 | Mansoor Amiji | Modulation of the Tumor Microenvironment with microrna Nano-Vectors | |
16:10 | Natalie Artzi | Biomaterials-aided combination immunotherapy | |
16:35 | Keynote lecture | Leaf Huang | Nano Intervention of Tumor Microenvironment to Improve Therapy |
17:10 | Closure day 1 | ||
friday 24 september 2021 | |||
Session 5: Tumor stroma and ECM - Session chair: Jai Prakash | |||
09:00 | Arne Östman | Identification of novel caf-subsets in colorectal and lung cancer with diffferential associations to driver mutations, immune features and outcome | |
09:25 | Erik Sahai | STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapy | |
09:50 | Luuk Hawinkels | Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease Cathepsin S | |
10:15 | Jen Morton | Targeting the Immune Microenvironment in Pancreatic Cancer | |
Session 6: Targeting metastasis - Session chair: Luuk Hawinkels | |||
10:40 | Isaac Witz | A vicious cycle of melanoma-microglia crosstalk promotes brain metastasis | |
11:05 | Janine Erler | Targeting the metastatic niche | |
11:30 | Break | ||
11:45 | Rajkumar Savai | Lung microenvironmental niche in cancerogenesis: What do fibrocytes have to offer? | |
Session 7: Short talks - Session chair: Helena Florindo | |||
12:05 | Fotios Mbekris | Dexamethasone normalizes tumor microenvironment and enhances efficacy of cisplatin-loaded nanocarrier in cancer | |
12:17 | Lee Shaashua-Berger | BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking CLU+ CAFs with HSF1 signaling | |
12:29 | Claudia Martins | Novel docetaxel nanomedicine meets the tumor microenvironment to defeat glioblastoma | |
12:41 | Shimrit Mayer | Characterizing fibroblast-macrophage signaling circuits in the tumor microenvironment | |
12:53 | Lunch | Breakrooms for discussion and networking | |
Session 8: Nano-targeted therapies and imaging of TME & Pitches - Session chair: Alberto Gabizon | |||
13:30 | Helena Florindo | Multifunctional nanovaccines for vascular regulation of antitumor immunity | |
13:55 | Marcelle Machluf | Nanoghost: Harnessing the power of stem cell to target and inhibit cancer growth | |
14:20 | Pitches - 27 each 1.5 min + 10 min discussion | ||
| |||
15:15 | Break | ||
Session 9: Nano-targeted therapies and imaging of TME - Session chair: Yuval Shaked | |||
15:30 | Michele De Palma | Mechanisms of microenvironmental tumor resistance to immune checkpoint blockade | |
15:55 | Miles Miller | Imaging the impacts of cellular phosphosignaling on nanotherapy action in tumors | |
16:20 | Twan Lammers | Pharmacological and Physical Priming of the Tumor Microenvironment | |
16:45 | Paolo Decuzzi | Hierarchically-structured polymeric drug delivery systems for cancer management | |
17:10 | Prizes and Closure | ||